Filana Therapeutics Inc (FLNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10 | 100 | 20 | 1 | 430 |
| Receivables | 10 | 0 | 0 | 0 | 170 |
| Inventories | 550 | 0 | 0 | 0 | 50 |
| Other current assets | 640 | 0 | 0 | 119 | 420 |
| TOTAL | $1,210 | $100 | $20 | $120 | $1,070 |
| Non-Current Assets | |||||
| PPE Net | 210 | 20 | 0 | 10 | 1,980 |
| Investments And Advances | 400 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 1,530 | 171 | 1,698 | 250 | 320 |
| TOTAL | $2,140 | $191 | $1,698 | $260 | $2,300 |
| Total Assets | $3,360 | $300 | $20 | $380 | $3,390 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 370 | 80 | 10 | 70 | 480 |
| Accrued Expenses | 520 | 400 | 0 | 0 | 90 |
| Other current liabilities | 0 | 280 | 0 | 0 | 240 |
| TOTAL | $900 | $1,010 | $10 | $70 | $830 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 0 | 0 | 0 | 300 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $300 |
| Total Liabilities | $900 | $1,010 | $10 | $70 | $1,130 |
| Shareholders' Equity | |||||
| Common Shares | 1,540 | 60 | 8 | 7 | 70 |
| Retained earnings | 0 | -14,150 | -12,470 | -12,030 | -7,090 |
| Other shareholders' equity | 10 | 10 | -4 | -7 | 70 |
| TOTAL | $2,460 | $-710 | $4 | $310 | $2,250 |
| Total Liabilities And Equity | $3,360 | $300 | $14 | $380 | $3,380 |